NeoGenomics Laboratories released the AML NanoMRD™ solution, a validated, off-the-shelf solution designed for low sample input and consistent deployment across clinical studies.
Public source
Publisher name
Public post
Our AML NanoMRD™ solution is a validated, off-the-shelf solution, designed for low sample input and consistent deployment across clinical studies. Contact us to learn mo…
Company
NeoGenomics Laboratories
Answers are in our DNA™
- Industry
- Hospitals and Health Care
- Location
- Fort Myers, US
- Company size
- 1,001–5,000 employees
About NeoGenomics Laboratories
Our vision: A world where every cancer treatment decision is as personal as the patient. Our mission: We take cancer personally. We partner with physicians to deliver actionable insights that guide personalized treatment decisions and improve outcomes -- through a comprehensive oncology portfolio and an unwavering commitment to excellence powered by a team of dedicated experts.
See moreLatest activity
Latest activity from NeoGenomics Laboratories
9 signals
Products & Services
NeoGenomics Laboratories launched Neo Comprehensive® for Myeloid Disorders testing, offering a single test for DNA and RNA alterations in a complete genomic view.
Products & Services
NeoGenomics Laboratories launched PTEN IHC CDx as part of PanTracer Pro, pairing IHC-based PTEN deficiency identification with comprehensive genomic profiling.
Presence & Recognition
NeoGenomics Laboratories presented research on AI-based detection and scoring of TROP2 expression in IHC-stained NSCLC specimens at AACR 2026, along with AI applications for automated phenotyping of multiplex immunofluorescence data.
Discover more
Similar signals
Similar public activity from other companies.
Products & Services
EMQN CIC
EMQN CIC launched a new Haemato-Oncology EQA category for the 2027 EQA Catalogue.
Products & Services
Labcorp
Labcorp launched the Marker by Labcorp Genetic Health Panel to help make personalized genetic insights more accessible through an easy-to-use experience.
Products & Services
GoPath Diagnostics
GoPath Diagnostics launched ProstateNow, a prostate-focused germline test designed to assess prognosis, therapeutic options, and inherited risk in patients and high-risk families.
Products & Services
ASP Health
ASP Health introduced The Clinical Experience, an ASP Health series bringing perspectives from pulmonology, pathology, and nursing to explore ROSE through the people who experience it.
Products & Services
Molecular Testing Labs